Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to.

Published bySukarno Kusnadi Modified over 5 years ago

Similar presentations

Presentation on theme: "Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to."— Presentation transcript:

1 Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to untreated controls (Con) after 24-hour treatment with forskolin (Fsk), transforming growth factor beta 1 (TGFB), or transforming growth factor beta 1 + forskolin (T/F). Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to untreated controls (Con) after 24-hour treatment with forskolin (Fsk), transforming growth factor beta 1 (TGFB), or transforming growth factor beta 1 + forskolin (T/F). Expression of FGF-7 and MBP significantly decreased with TGFB and T/F treatments (n=3, P<0.05). Doan Nguyen, and Olawale A. R. Sulaiman TOJ 2019;19:7-12 Copyright © by the author(s); Creative Commons Attribution License (CC BY)‏

Download ppt "Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to."

Similar presentations

Copyright Crash Course Laura Rivera EDTC 6340.62.

Copyright Crash Course Laura Rivera EDTC
Pentoxifylline Attenuates Transforming Growth Factor-β1-Stimulated Collagen Deposition and Elastogenesis in Human Tunica Albuginea-Derived Fibroblasts.

Pentoxifylline Attenuates Transforming Growth Factor-β1-Stimulated Collagen Deposition and Elastogenesis in Human Tunica Albuginea-Derived Fibroblasts.
Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease Nephron Clin Pract 2013;123:61-66 - DOI:10.1159/000351811.

Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease Nephron Clin Pract 2013;123: DOI: /
Michael Blaber Biomedical Sciences

Michael Blaber Biomedical Sciences
TGF-β isoforms in renal fibrogenesis

TGF-β isoforms in renal fibrogenesis
Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor β-3  Doina S. Joseph, M.S., Minnie Malik, Ph.D., Sahadat.

Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor β-3  Doina S. Joseph, M.S., Minnie Malik, Ph.D., Sahadat.
Activation of Adenylyl Cyclase Reduces TGF-β Profibrotic Response in Osteoarthritic Fibroblast-Like Synoviocytes  M. Qadri, R. Ostrom, K.A. Elsaid  Osteoarthritis.

Activation of Adenylyl Cyclase Reduces TGF-β Profibrotic Response in Osteoarthritic Fibroblast-Like Synoviocytes  M. Qadri, R. Ostrom, K.A. Elsaid  Osteoarthritis.
Effects of neuropeptide treatment on APC stimulation of Ag-specific T cells. Effects of neuropeptide treatment on APC stimulation of Ag-specific T cells.

Effects of neuropeptide treatment on APC stimulation of Ag-specific T cells. Effects of neuropeptide treatment on APC stimulation of Ag-specific T cells.
Chi-Hyun Park, Youngji Moon, Chung Min Shin, Jin Ho Chung 

Chi-Hyun Park, Youngji Moon, Chung Min Shin, Jin Ho Chung 
Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal- stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor 

Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal- stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor 
Fig. 3 Conserved genomic association of PRC1 activity in different leukemic cells. Conserved genomic association of PRC1 activity in different leukemic.

Fig. 3 Conserved genomic association of PRC1 activity in different leukemic cells. Conserved genomic association of PRC1 activity in different leukemic.
Fig. 5 Correlation of RNA expression and protein abundance.

Fig. 5 Correlation of RNA expression and protein abundance.
(A) Single photon emission computed tomography (SPECT) image of the brain. (Reprinted from Vigren P et al.11 Copyright 2014 licensed by Creative Commons.

(A) Single photon emission computed tomography (SPECT) image of the brain. (Reprinted from Vigren P et al.11 Copyright 2014 licensed by Creative Commons.
Fig. 2 The SOS response is required for persistence to ofloxacin but not prior treatment. The SOS response is required for persistence to ofloxacin but.

Fig. 2 The SOS response is required for persistence to ofloxacin but not prior treatment. The SOS response is required for persistence to ofloxacin but.
Fig. 3 Cytosolic delivery of fluorescent proteins.

Fig. 3 Cytosolic delivery of fluorescent proteins.
Fig. 5. (A) The effect of PKA and PI3K inhibitors on VEGF production in NPDFs. KT5720 and LY294002 significantly decreased VEGF production. (B) The effect.

Fig. 5. (A) The effect of PKA and PI3K inhibitors on VEGF production in NPDFs. KT5720 and LY significantly decreased VEGF production. (B) The effect.
Fig. 4 Restoration of MTAP expression produces heterogeneous effects on metabolism. Restoration of MTAP expression produces heterogeneous effects on metabolism.

Fig. 4 Restoration of MTAP expression produces heterogeneous effects on metabolism. Restoration of MTAP expression produces heterogeneous effects on metabolism.
Fig. 4 Mutations and reduced expression of human KDM6A predict poor prognosis of female patients with BCa. Mutations and reduced expression of human KDM6A.

Fig. 4 Mutations and reduced expression of human KDM6A predict poor prognosis of female patients with BCa. Mutations and reduced expression of human KDM6A.
Fig. 4 The TORC1/TORC2 pathway controls the level of the Elongator-dependent modifications. The TORC1/TORC2 pathway controls the level of the Elongator-dependent.

Fig. 4 The TORC1/TORC2 pathway controls the level of the Elongator-dependent modifications. The TORC1/TORC2 pathway controls the level of the Elongator-dependent.
Fig. 3 Projected gains in MCP.

Fig. 3 Projected gains in MCP.

Similar presentations

Ads by Google